Skip to main content
Premium Trial:

Request an Annual Quote

NCI Renews 'Comprehensive' Status for UCSD's Moores Center, Grants $21M

NEW YORK (GenomeWeb News) — The National Cancer Institute has renewed the Moores Cancer Center’s status as a Comprehensive Cancer Center and has funded it with $21 million over five years, the University of California at San Diego said this week.
 
UCSD said it will use the grant to fund research costs and operational expenses for its 10 core facilities, which include labs and hardware for DNA sequencing, microarraying, bioinformatics, clinical trials, and other genomics, imaging, and cancer-related development endeavors.
 
The center, one of 40 nationwide designated a Comprehensive Cancer Center, has a staff of 330 researchers and clinicians. It moved into a 270,000-square-foot building in 2005.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.